Effect of Sitagliptin on Postprandial Lipoprotein Metabolism

Ludwig Maximilian University of Munich

Status and phase: Terminated; Phase 4

Conditions: Diabetes Mellitus Type 2

Treatments: Drug: glimepiride; Drug: sitagliptin

Study type: Interventional

Funder types: Other

Identifiers

NCT00939939

KP MSD 01-08

Details and patient eligibility

About

The goal of the study is to evaluate whether sitagliptin can affect postprandial lipoprotein metabolism in type 2 diabetic patients.

Enrollment: 3 patients

Sex: All

Ages: 19 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• type 2 diabetes
• dietary therapy

Exclusion criteria

• lipid-lowering therapy
• anti-hyperglycemic drug therapy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

3 participants in 2 patient groups

sitagliptin

Experimental group

Treatment:

Drug: sitagliptin

glimepirid

Active Comparator group

Treatment:

Drug: glimepiride